Valuation (59%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 21.42 | N/A |
| PEG Ratio (TTM) | -3.69 | N/A |
| P/S Ratio (TTM) | 2.62 | N/A |
| P/B Ratio (TTM) | 1.12 | N/A |
| P/FCF Ratio (TTM) | -37.50 | N/A |
| Price to 5YR AVG Earnings Ratio | 7.28 | N/A |
| Price to 5YR AVG FCF Ratio | 4.13 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.48% | N/A |
| ROE (TTM) | 5.29% | N/A |
| Net Profit Margin (TTM) | 12.86% | N/A |
| ROIC 5YR AVG | 8.89% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -4.34% | 31.89% | 21.86% |
| Revenue | 13.84% | 45.65% | 25.05% |
| Net Income | -1.53% | 44.42% | 28.59% |
| Cash Flow | -91.16% | 61.50% | 43.40% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.39 | N/A |
| Quick Ratio (TTM) | 0.39 | N/A |
| D/E Ratio (TTM) | 0.62 | N/A |
| Interest Coverage (TTM) | 0.29 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.09 | N/A |
| LTL to 5YR AVG FCF | 0.96 | N/A |
| Shares Outstanding Growth 5YR AVG | 8.35% | N/A |